Australia Stock Exchange release from ISLAND PHARMACEU : ISLA-101 Phase 2a clinical trial update
08/11/2021 22:26
Australia Stock Exchange release from ISLAND PHARMACEU ILA.AX : ISLA-101 Phase 2a clinical trial update
Recent news on Island Pharmaceuticals
See all newsBrief: Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA Pathway
Brief: Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million
Australia's Island Pharmaceuticals rises as company boosts Galidesivir production
Brief: Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges
Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic